1994
DOI: 10.1016/0360-3016(94)90141-4
|View full text |Cite
|
Sign up to set email alerts
|

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose-escalation study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
0
3

Year Published

1995
1995
2011
2011

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 159 publications
(22 citation statements)
references
References 48 publications
1
18
0
3
Order By: Relevance
“…The Stanford University material now includes over 900 patients, the majority being early stage (Tl-T2) cases, and over 15 years' follow-up (1 I). These original results have been confirmed in many other series (12)(13)(14)(15)(16)(17)(18)(19)(20).…”
Section: Radiation Therapy Of Prostate Cancer Retrospective Studiessupporting
confidence: 74%
“…The Stanford University material now includes over 900 patients, the majority being early stage (Tl-T2) cases, and over 15 years' follow-up (1 I). These original results have been confirmed in many other series (12)(13)(14)(15)(16)(17)(18)(19)(20).…”
Section: Radiation Therapy Of Prostate Cancer Retrospective Studiessupporting
confidence: 74%
“…Segmental and hyperfractionated radiotherapy are usually delivered with < 50 MU settings [5,13]. The conformal therapy makes use of multiple multileaf collimated (MLC) beams of varying intensities delivered with automatic computer controls [14][15][16]. Sometimes the number of MU per field might vary as low as 10 MU depending on the location of the target and the neighboring normal structures [1,8,17,18,25].…”
Section: Introductionmentioning
confidence: 99%
“…The 'high-dose volume' of critical structures (rectum and bladder), covered by 90% isodose, can be reduced by more than 40% in comparison with conventional techniques (1). Several retrospective studies showed, that the dosimetric advantages of 3D-CRT were associated with acute morbidity reduction (2)(3)(4).…”
Section: Original Articlementioning
confidence: 99%